Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
10 October 2024
| Name: | APOLLO LIFE SCIENCES LIMITED (AOP) (This company subsequently changed its name and is now APOLLO CONSOLIDATED LIMITED. You should refer to that name for Status.) | ||||||
| Date of Listing: | 29 June 2005 | ||||||
| Subsequent Names: |
|
Stock Exchange Status:
This company subsequently changed its name and is now APOLLO CONSOLIDATED LIMITED. You should refer to that name for Stock Exchange Status.Legal Status:
This company subsequently changed its name and is now APOLLO CONSOLIDATED LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status:
This company subsequently changed its name and is now APOLLO CONSOLIDATED LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| APOLLO CONSOLIDATED LIMITED | 09/09/2009 | |
| APOLLO LIFE SCIENCES LIMITED | 09/09/2009 |
REGISTRY:
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail
name changed to Apollo Consolidated Limited | 09/09/2009 |
releases a consolidation (1 for 20) timetable and that resolutions considered at the meeting yesterday were passed | 05/08/2009 |
a General Meeting is to be held at 11:00 am (EST), on 4 August 2009 at the offices of Pitcher Partners, Level 22 MLC Centre, 19 Martin Place, Sydney, New South Wales to consider the restructure (including a consolidation of 1 for 20) and recapitalisation of the company | 03/07/2009 |
the Deed Administrators report that creditors have resolved to accept a recapitalisation proposal | 14/05/2009 |
the Deed Administrators report that Apollo's plant & equipment has been sold by auction and the marketing of its intellectual property continues - they are currently negotiating a proposal for the recapitalisation of Apollo - shareholders will be contacted with full details of the recapitalisation proposal shortly | 10/02/2009 |
company enters into a Deed of Company Arrangement (DOCA) - the DOCA allows David Young and Anthony Elkerton, the Joint Deed Administrators time to conclude their investigations into Apollo's affairs and conclude their dealings in relation to the sale of Apollo's assets and/or restructure of its share capital with a view to re-listing Apollo on the ASX for the benefit of creditors and shareholders - the deadline for offers to be received for Apollo's assets is 16 January 2009 | 03/12/2008 |
creditors resolve to enter into a Deed of Company arrangement | 26/11/2008 |
the administrators are offering the major assets of the company and its subsidiaries for sale | 03/11/2008 |
company appoints administrators Anthony Elkerton and David Young of Pitcher Partners - this is never good for shareholders but it will be a month or so before a clearer picture emerges | 24/10/2008 |
funding of $2m from John Priest previously reported as being secured is now not going to proceed | 23/10/2008 |
releases preliminary final report | 29/08/2008 |
none of the resolutions considered at today's general meeting were approved | 19/08/2008 |
a general meeting of Apollo Life Sciences Limited ("Company") will be held on 19 August 2008 at 10.00 a.m. at 147 Queen Street, Beaconsfield NSW 2015 | 21/07/2008 |
company confirms the restructuring phase of its three-phase program is almost complete and the consolidation phase about to begin | 04/07/2008 |
company advises a meeting of shareholders has been requisitioned and it will advise details to shareholders later | 23/06/2008 |
advises of the signing of an agreement regarding the licensing of its research proteins business | 10/06/2008 |
announces the signing of a Heads of Agreement regarding the licensing of its research proteins business | 16/05/2008 |
releases its quarterly cash report to 31 March 2008 showing a deficit at operating level for the quarter of $1.78m | 30/04/2008 |
company announces it has engaged Deloitte Touche Tohmatsu to advise the Apollo Board of Directors on their restructure of the Apollo business and in particular the strategic sale of certain business assets owned by Apollo | 23/04/2008 |
the company confirms that it is currently implementing its notified restructure strategy with a three stage process of restructuring, consolidation and value-creation - the restructuring, which includes the orderly realisation of non-core assets as a going concern with an aim to pay creditors in full, is scheduled to continue through to June | 15/04/2008 |
Apollo is implementing its notified strategy of reducing costs and realising non-core assets - as part of the cost reduction process, the retainer-based contracts of Diabetes Advisory Board members which expired in March have not been renewed - the majority of full scientific advisory board members, including researchers with expertise in the diabetes field, are engaged on a different basis and continue in their roles | 01/04/2008 |
securities of Apollo Life Sciences Limited (the "Company") will be suspended from quotation immediately, at the request of the Company in accordance with listing rule 17.2, following the Company's announcement in relation to a strategic review involving the sale of assets and uncertainty relating to the ability of the Company to operate as a going concern | 18/03/2008 |
name changed to Apollo Consolidated Limited | 09/09/2009 |
releases a consolidation (1 for 20) timetable and that resolutions considered at the meeting yesterday were passed | 05/08/2009 |
a General Meeting is to be held at 11:00 am (EST), on 4 August 2009 at the offices of Pitcher Partners, Level 22 MLC Centre, 19 Martin Place, Sydney, New South Wales to consider the restructure (including a consolidation of 1 for 20) and recapitalisation of the company | 03/07/2009 |
the Deed Administrators report that creditors have resolved to accept a recapitalisation proposal | 14/05/2009 |
the Deed Administrators report that Apollo's plant & equipment has been sold by auction and the marketing of its intellectual property continues - they are currently negotiating a proposal for the recapitalisation of Apollo - shareholders will be contacted with full details of the recapitalisation proposal shortly | 10/02/2009 |
company enters into a Deed of Company Arrangement (DOCA) - the DOCA allows David Young and Anthony Elkerton, the Joint Deed Administrators time to conclude their investigations into Apollo's affairs and conclude their dealings in relation to the sale of Apollo's assets and/or restructure of its share capital with a view to re-listing Apollo on the ASX for the benefit of creditors and shareholders - the deadline for offers to be received for Apollo's assets is 16 January 2009 | 03/12/2008 |
creditors resolve to enter into a Deed of Company arrangement | 26/11/2008 |
the administrators are offering the major assets of the company and its subsidiaries for sale | 03/11/2008 |
company appoints administrators Anthony Elkerton and David Young of Pitcher Partners - this is never good for shareholders but it will be a month or so before a clearer picture emerges | 24/10/2008 |
funding of $2m from John Priest previously reported as being secured is now not going to proceed | 23/10/2008 |
releases preliminary final report | 29/08/2008 |
none of the resolutions considered at today's general meeting were approved | 19/08/2008 |
a general meeting of Apollo Life Sciences Limited ("Company") will be held on 19 August 2008 at 10.00 a.m. at 147 Queen Street, Beaconsfield NSW 2015 | 21/07/2008 |
company confirms the restructuring phase of its three-phase program is almost complete and the consolidation phase about to begin | 04/07/2008 |
company advises a meeting of shareholders has been requisitioned and it will advise details to shareholders later | 23/06/2008 |
advises of the signing of an agreement regarding the licensing of its research proteins business | 10/06/2008 |
announces the signing of a Heads of Agreement regarding the licensing of its research proteins business | 16/05/2008 |
releases its quarterly cash report to 31 March 2008 showing a deficit at operating level for the quarter of $1.78m | 30/04/2008 |
company announces it has engaged Deloitte Touche Tohmatsu to advise the Apollo Board of Directors on their restructure of the Apollo business and in particular the strategic sale of certain business assets owned by Apollo | 23/04/2008 |
the company confirms that it is currently implementing its notified restructure strategy with a three stage process of restructuring, consolidation and value-creation - the restructuring, which includes the orderly realisation of non-core assets as a going concern with an aim to pay creditors in full, is scheduled to continue through to June | 15/04/2008 |
Apollo is implementing its notified strategy of reducing costs and realising non-core assets - as part of the cost reduction process, the retainer-based contracts of Diabetes Advisory Board members which expired in March have not been renewed - the majority of full scientific advisory board members, including researchers with expertise in the diabetes field, are engaged on a different basis and continue in their roles | 01/04/2008 |
securities of Apollo Life Sciences Limited (the "Company") will be suspended from quotation immediately, at the request of the Company in accordance with listing rule 17.2, following the Company's announcement in relation to a strategic review involving the sale of assets and uncertainty relating to the ability of the Company to operate as a going concern | 18/03/2008 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Timothy Blackwell | CFO | 16/05/2007 |
| Alex Neuling | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| John Priest | Chairman, CEO | 12/09/2002 | 04/08/2009 |
| Tony Basten | Director | 04/08/2009 | |
| Paul Murnane | Director | 22/04/2004 | 04/08/2009 |
| Gregory Russell-Jones | Director | 25/05/2006 | 19/06/2007 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
